A Study Comparing Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX (SELECT-MONOTHERAPY)

NCT02706951 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

648

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Methotrexate
DRUG: Upadacitinib
DRUG: Placebo Upadacitinib
DRUG: Placebo Methotrexate

Sponsor

AbbVie